1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Familial Adenomatous Polyposis Coli Global Clinical Trials Review, H2, 2015

Familial Adenomatous Polyposis Coli Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Familial Adenomatous Polyposis Coli Global Clinical Trials Review, H2, 2015" provides an overview of Familial Adenomatous Polyposis Coli clinical trials scenario. This report provides top line data relating to the clinical trials on Familial Adenomatous Polyposis Coli. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Familial Adenomatous Polyposis Coli Global Clinical Trials Review, H2, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Familial Adenomatous Polyposis Coli 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Clinical Trials by G7 Countries: Proportion of Familial Adenomatous Polyposis Coli to Genetic Disorders Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by Phase 17
In Progress Trials by Phase 18
Clinical Trials by Trial Status 19
Clinical Trials by End Point Status 20
Unaccomplished Trials of Familial Adenomatous Polyposis Coli 21
Subjects Recruited Over a Period of Time 23
Clinical Trials by Sponsor Type 24
Prominent Sponsors 25
Top Companies Participating in Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials 26
Prominent Drugs 27
Clinical Trial Profiles 28
Clinical Trial Overview of Top Companies 28
Zeria Pharmaceutical Co Ltd 28
Clinical Trial Overview of Zeria Pharmaceutical Co Ltd 28
S.L.A. Pharma AG 29
Clinical Trial Overview of S.L.A. Pharma AG 29
Pfizer Inc. 30
Clinical Trial Overview of Pfizer Inc. 30
Thetis Pharmaceuticals LLC 31
Clinical Trial Overview of Thetis Pharmaceuticals LLC 31
SignPath Pharma Inc 32
Clinical Trial Overview of SignPath Pharma Inc 32
Onxeo SA 33
Clinical Trial Overview of Onxeo SA 33
Merck and Co., Inc. 34
Clinical Trial Overview of Merck and Co., Inc. 34
Marina Biotech, Inc. 35
Clinical Trial Overview of Marina Biotech, Inc. 35
Bayer AG 36
Clinical Trial Overview of Bayer AG 36
Aptalis Pharma Inc. (Inactive) 37
Clinical Trial Overview of Aptalis Pharma Inc. (Inactive) 37
Clinical Trial Overview of Top Institutes / Government 38
Kyoto Prefectural University of Medicine 38
Clinical Trial Overview of Kyoto Prefectural University of Medicine 38
National Cancer Institute 39
Clinical Trial Overview of National Cancer Institute 39
Radboud University 40
Clinical Trial Overview of Radboud University 40
The Tel Aviv Sourasky Medical Center 41
Clinical Trial Overview of The Tel Aviv Sourasky Medical Center 41
The University of Texas M. D. Anderson Cancer Center 42
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 42
Assistance Publique - Hopitaux de Paris 43
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 43
CSIRO Food and Nutritional Sciences 44
Clinical Trial Overview of CSIRO Food and Nutritional Sciences 44
Emory University 45
Clinical Trial Overview of Emory University 45
Leiden University Medical Center 46
Clinical Trial Overview of Leiden University Medical Center 46
Mayo Clinic 47
Clinical Trial Overview of Mayo Clinic 47
Five Key Clinical Profiles 48
Appendix 76
Abbreviations 76
Definitions 76
Research Methodology 77
Secondary Research 77
About GlobalData 78
Contact Us 78
Disclaimer 78
Source 79

List of Tables
Familial Adenomatous Polyposis Coli Therapeutics, Global, Clinical Trials by Region, 2015* 7
Familial Adenomatous Polyposis Coli Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Familial Adenomatous Polyposis Coli Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 10
Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Proportion of Familial Adenomatous Polyposis Coli to Genetic Disorders Clinical Trials, G7 Countries (%), 2015* 14
Familial Adenomatous Polyposis Coli Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15
Familial Adenomatous Polyposis Coli Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16
Familial Adenomatous Polyposis Coli Therapeutics, Global, Clinical Trials by Phase, 2015* 17
Familial Adenomatous Polyposis Coli Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 18
Familial Adenomatous Polyposis Coli Therapeutics, Global, Clinical Trials by Trial Status, 2015* 19
Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials, Global, by End Point Status, 2015* 20
Familial Adenomatous Polyposis Coli Therapeutics, Global, Withdrawn Clinical Trials, 2015* 21
Familial Adenomatous Polyposis Coli Therapeutics, Global, Terminated Clinical Trials, 2015* 22
Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 23
Familial Adenomatous Polyposis Coli Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 24
Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 25
Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 26
Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 27
Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials Market, Global, Clinical Trials by Zeria Pharmaceutical Co Ltd, 2015* 28
Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials Market, Global, Clinical Trials by S.L.A. Pharma AG, 2015* 29
Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 30
Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials Market, Global, Clinical Trials by Thetis Pharmaceuticals LLC, 2015* 31
Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials Market, Global, Clinical Trials by SignPath Pharma Inc, 2015* 32
Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials Market, Global, Clinical Trials by Onxeo SA, 2015* 33
Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck and Co., Inc., 2015* 34
Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials Market, Global, Clinical Trials by Marina Biotech, Inc., 2015* 35
Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015* 36
Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials Market, Global, Clinical Trials by Aptalis Pharma Inc. (Inactive), 2015* 37
Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyoto Prefectural University of Medicine, 2015* 38
Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2015* 39
Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials Market, Global, Clinical Trials by Radboud University, 2015* 40
Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials Market, Global, Clinical Trials by The Tel Aviv Sourasky Medical Center, 2015* 41
Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2015* 42
Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2015* 43
Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials Market, Global, Clinical Trials by CSIRO Food and Nutritional Sciences, 2015* 44
Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2015* 45
Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials Market, Global, Clinical Trials by Leiden University Medical Center, 2015* 46
Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2015* 47

List of Figures
Familial Adenomatous Polyposis Coli Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Familial Adenomatous Polyposis Coli Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Familial Adenomatous Polyposis Coli Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 10
Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13
Proportion of Familial Adenomatous Polyposis Coli to Genetic Disorders Clinical Trials, G7 Countries (%), 2015* 14
Familial Adenomatous Polyposis Coli Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15
Familial Adenomatous Polyposis Coli Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16
Familial Adenomatous Polyposis Coli Therapeutics, Global, Clinical Trials by Phase (%), 2015* 17
Familial Adenomatous Polyposis Coli Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 18
Familial Adenomatous Polyposis Coli Therapeutics, Global, Clinical Trials by Trial Status, 2015* 19
Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials, Global, by End Point Status, 2015* 20
Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 23
Familial Adenomatous Polyposis Coli Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 24
Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 25
Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 26
Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 27
GlobalData Methodology 77

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.